1. | amores51049 | |
2. | agngolf | |
3. | TTrade333 | |
4. | WillSchibler79 | |
5. | suzie954403 |
1. | amores51049 | |
2. | agngolf | |
3. | TTrade333 | |
4. | WillSchibler79 | |
5. | suzie954403 |
1. | WillSchibler79 03/26/2018 Presented data from TOPACIO trial of niraparib in combination with anti-PD-1 monoclonal antibody, KEYTRUDA; … |
2. | TTrade333 05/03/2018 Misses |
3. | WillSchibler79 02/26/2018 Enters into clinical collaboration with Roche's Genentech |
4. | TTrade333 06/20/2018 Intereconomia reports that Roche is apparently studying an acquisition of the company |
5. | suzie954403 08/03/2018 Chart |
6. | amores51049 01/13/2018 Relevant News: - TESARO Announces Updates to the U.S. Prescribing Information for VARUBI® (rolapitant) Injectable Emulsion |
7. | wasserleiche 05/04/2018 TESARO Announces First-Quarter 2018 Operating Results |
8. | amores51049 04/16/2018 TESARO Summarizes TSR-042 Clinical Data Presented at AACR |
9. | agngolf 02/27/2018 TESARO Announces Collaboration to Evaluate Combination of ZEJULA® (Niraparib) and Anti-PD-L1 Cancer Immunotherapy in Metastatic Bladder Cancer |
10. | WillSchibler79 10/25/2017 Big news, FDA Approval |